(Q43743678)

English

The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes

scientific article published on 19 October 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

3

object named as

Jan Wilschut

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Tjarko Meijerhof

2

object named as

Tjarko Meijerhof

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

4

object named as

Anke Huckriede

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Natalija Budimir

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Aalzen de Haan

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

19 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

8280-8287

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Seasonal influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Single-amino-acid mutation in the HA alters the recognition of H9N2 influenza virus by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Pandemic influenza threat and preparedness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Antigen processing and presentation by the class I major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Intracellular mechanisms of antigen cross presentation in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

MHC molecules and microbial antigen processing in phagosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Cellular mechanisms governing cross-presentation of exogenous antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Strategies for cytosolic delivery of liposomal macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Biodegradable nanoparticles for cytosolic delivery of therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

The virosome concept for influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Cross-priming in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

A simplification of the protein assay method of Lowry et al. which is more generally applicable

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

An in vivo cytotoxicity threshold for influenza A virus-specific effector and memory CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Response of naïve and memory CD8+ T cells to antigen stimulation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Phagosomes are competent organelles for antigen cross-presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Designing CD8+ T cell vaccines: it's not rocket science (yet).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.007

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.10.007

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43743678&oldid=2102983441"